-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MPd2YP3fa7OKE/GlR74odNyHEcBatzvSm676Q4bptZiziVYgiqAwmLI5arH4qeDw GbUSGszW79r3oPK+AvT+Xg== 0000950133-01-501817.txt : 20010710 0000950133-01-501817.hdr.sgml : 20010710 ACCESSION NUMBER: 0000950133-01-501817 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20010709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-32142 FILM NUMBER: 1676349 BUSINESS ADDRESS: STREET 1: 8320 GUILFORD RD STREET 2: STE C CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 3078543900 MAIL ADDRESS: STREET 1: 8320 GUILFORD ROAD SUITE C STREET 2: 12111 PARKLAWN DR CITY: COLUMBIA STATE: MD ZIP: 21046 424B3 1 w50832e424b3.htm 424B3 e424b3

Filed pursuant to Rule 424(b)(3)
File No. 333-32142

NOVAVAX, INC.

SUPPLEMENT NO. 1 DATED JULY 9, 2001
TO PROSPECTUS DATED MARCH 16, 2000

      This Supplement contains information relating to the table under the caption “Selling Stockholders” in our March 16, 2000 prospectus.

      Mr. John Lamb has transferred certain restricted shares of our common stock to CIBC Oppenheimer, a subsidiary of CIBC World Market (“CIBC”). As a result of this transaction, the disclosures concerning Selling Stockholders is updated to include CIBC as follows:

                                 
Number of Shares Owned Maximum Number
Prior to Offering of Shares
Name of Selling Stockholder Shares Warrants Total Being Offered
 
CIBC Oppenheimer, a 25,000 25,000 25,000
subsidiary of CIBC
World Market

-----END PRIVACY-ENHANCED MESSAGE-----